Synopsis:
Navin Fluorine International Ltd announced Q1 FY26 Results PAT surged by 128% YoY.

The shares of this chemical company, which is engaged in refrigeration gases, inorganic fluorides and others, are in the spotlight after the announcement of its Q1 business results.

Navin Fluorine International Ltd is a large-cap company with a market capitalization of Rs.27,488 crores. It opened at Rs.5,099.95 per equity share from its previous day’s closing price Rs.5,185.80 and made an intraday high of Rs.5,442.25 (5 percent) per equity share.

Quarterly Update

In Q1 FY26, Navin Fluorine International Ltd reported revenue of Rs.725 crores, marking an increase of 3.5 percent quarter-on-quarter from Rs.701 crores in Q4 FY25. The company also posted a profit after tax of Rs.117 crores in Q1 FY26, up from Rs.95 crores in the previous quarter, showing solid improvement of 23 percent in  profitability.

Year-on-year, the company’s revenue from operations rose by 38.5 percent, increasing from Rs.523.6 crores in Q1 FY25 to Rs.725 crores in Q1 FY26. In terms of profitability, the company reported a net profit of Rs.51.20 crores in Q1 FY25, which further improved to Rs.117  crores in Q1 FY26. This reflects a positive growth of 128 percent  in profit compared to the same period last year.

Also Read: Auto ancillary stocks likely to be affected by Donald Trump’s 25% tariff on India

Company Profile

Navin Fluorine International Ltd is one of India’s top and most trusted makers of specialty fluorochemicals. It was started in 1967 and is part of the Padmanabh Mafatlal Group, one of India’s oldest business families.

The company has large manufacturing plants in Surat and Dahej , and Dewas. It also has a dedicated research and innovation center in Surat called NRIC (Navin Research Innovation Center).

The company produces over 60 types of fluorine-based chemicals used in many industries like pharmaceuticals, crop protection, and specialty chemicals. Some of its key products include R-22 refrigerant gas, anhydrous hydrofluoric acid (AHF), and boron trifluoride.

NFIL is known for its strong research and development capabilities, helping clients with custom chemical development, from small lab samples to full-scale production. It also has a UK-based subsidiary, Manchester Organics, that supports early-stage drug and chemical discovery.

Over 40 percent of NFIL’s products are exported to countries in North America, Europe, the Middle East, and Asia-Pacific. The company is a trusted partner for many global customers, including several Fortune 500 companies.

Written by Sudeep Kumbar

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.